Siyuan Huang

Siyuan Huang

Auto-generated profile, based on publicly available information

Siyuan Huang

Eli Lilly and Company, Lilly Research Laboratories, Lilly Corporate Center, Synthetic Molecule Design and Development, Indianapolis, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
SHSiyuan Huang
Siyuan Huang
KOKevin P. O'DOnnell
Kevin P. O'DOnnell
SVSophie M. Delpon de Vaux
Sophie M. Delpon de Vaux
JOJohn O'BRien
John O'BRien
JSJohn Stutzman
John Stutzman
Robert Williams IIIRobert Williams III
Robert Williams III

1 April 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
XMXIANGYU MA
XIANGYU MA
SHSiyuan Huang
Siyuan Huang
MLMichael Lowinger
Michael Lowinger
XLXu Liu
Xu Liu
XLXingyu Lu
Xingyu Lu
Robert Williams IIIRobert Williams III
Robert Williams III

20 April 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
XMXIANGYU MA
XIANGYU MA
FMFelix Müller
Felix Müller
SHSiyuan Huang
Siyuan Huang
MLMichael Lowinger
Michael Lowinger
XLXu Liu
Xu Liu
Robert Williams IIIRobert Williams III
Robert Williams III
Amorphous solid dispersions (ASDs) are commonly used in the pharmaceutical industry to improve the dissolution and bioavailability of poorly water-soluble drugs. Hot melt extrusion (HME) has been employed to prepare ASD based products. However, due to the narrow processing window of HME, ASDs are normally obtained with high processing temperatures and mechanical stress. Interestingly, one-third of pharmaceutical compounds reportedly exist in hydrate forms. In this study, we selected carbamazepine (CBZ) dihydrate to investigate its solid-state changes during the dehydration process and the impact of the dehydration on the preparation of CBZ ASDs using a Leistritz micro-18 extruder. Various characterization techniques were used to study the dehydration kinetics of CBZ dihydrate under different conditions. We designed the extrusion runs and demonstrated that: 1) the dehydration of CBZ dihydrate resulted in a disordered state of the drug molecule; 2) the resulted higher energy state CBZ facilitated the drug solubilization and mixing with the polymer matrix during the HME process, which significantly decreased the required extrusion temperature from 140 to 60 °C for CBZ ASDs manufacturing compared to directly processing anhydrous crystalline CBZ. This work illustrated that the proper utilization of drug hydrates can significantly improve the processability of HME for preparing ASDs.

1 November 2024 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
PXPengchong Xu
Pengchong Xu
HNHanh Thuy Nguyen
Hanh Thuy Nguyen
SHSiyuan Huang
Siyuan Huang
HTHuyen Tran
Huyen Tran

20 May 2022
Verified
Book Chapter
Closed access
PDF file
MJMiguel Jara
Miguel Jara
JHJustin R. Hughey
Justin R. Hughey
SHSiyuan Huang
Siyuan Huang
Robert Williams IIIRobert Williams III
Robert Williams III